Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCT analysis of cystoid macular edema in uveitis patients treated with sub-Tenon triamcinolone
2008-004899-50Phase 3Terminated
- Sponsor
- Policlinico Gemelli
- Start
- Jul 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of triamcinolone acetonide in cystoid macular edema (CME) and uveitis, sponsored by Policlinico Gemelli. Primary endpoint: Efficacy of sub-Tenon triamcinolone acetonide 40 mg on cystoid macular edema secondary to uveitis. Started Jul 2008; status: terminated.
02
Drugs
triamcinolone acetonide
03
Conditions
cystoid macular edema (CME)uveitis
Beyond the preview
Go deeper on 2008-004899-50.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004899-50.